<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Multiple <z:hpo ids='HP_0100568'>endocrine neoplasia</z:hpo> type 2 (MEN 2) is transmitted as an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> trait, with 3 different forms </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0025268" disease_type="Neoplastic Process" abbrv="MEN2a">MEN 2a</z:e> consists of <z:hpo ids='HP_0002865'>medullary thyroid carcinoma</z:hpo>, <z:e sem="disease" ids="C0031511" disease_type="Neoplastic Process" abbrv="">phaeochromocytoma</z:e>(s) and <z:hpo ids='HP_0000843'>hyperparathyroidism</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In <z:e sem="disease" ids="C0025269" disease_type="Neoplastic Process" abbrv="MEN2b">MEN 2b</z:e>, <z:hpo ids='HP_0008208'>parathyroid hyperplasia</z:hpo> is absent, but a Marfan-like syndrome and <z:e sem="disease" ids="C0027858" disease_type="Neoplastic Process" abbrv="">neuromas</z:e> of the mucosae are present </plain></SENT>
<SENT sid="3" pm="."><plain>In some families, the only manifestation of MEN 2 is a <z:hpo ids='HP_0002865'>medullary thyroid carcinoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>These 3 forms seem to related to one or several gene(s) located in the pericentromeric region of chromosome 10 </plain></SENT>
<SENT sid="5" pm="."><plain>The histological lesions of <z:e sem="disease" ids="C0025268" disease_type="Neoplastic Process" abbrv="MEN2a">MEN 2a</z:e> are multifocal, bilateral and associated with <z:mpath ids='MPATH_134'>hyperplasia</z:mpath> (which affects C-cells in the thyroid gland) </plain></SENT>
<SENT sid="6" pm="."><plain>Screening for familial <z:hpo ids='HP_0002865'>medullary thyroid carcinoma</z:hpo> is based upon plasma calcitonin levels measured before and after a pentagastrin stimulation test </plain></SENT>
<SENT sid="7" pm="."><plain>The demonstration of DNA markers near the gene(s) of the disease in chromosome 10 pericentromeric region makes it possible to identify, with good probability, the subjects at risk for the disease </plain></SENT>
<SENT sid="8" pm="."><plain>It is only by determining the responsible gene(s) that subjects carrying the hereditary anomaly will be identified directly, without marker assays </plain></SENT>
</text></document>